Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea flag South Korea · Delayed Price · Currency is KRW
48,700
+3,600 (7.98%)
At close: Jul 18, 2025, 3:30 PM KST

Next Biomedical Revenue

Next Biomedical had revenue of 3.77B KRW in the quarter ending March 31, 2025, with 165.94% growth. This brings the company's revenue in the last twelve months to 10.95B, up 124.19% year-over-year. In the year 2024, Next Biomedical had annual revenue of 9.54B with 95.46% growth.

Revenue (ttm)
10.95B
Revenue Growth
+124.19%
P/S Ratio
36.16
Revenue / Employee
n/a
Employees
n/a
Market Cap
395.78B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20249.54B4.66B95.46%
Dec 31, 20234.88B2.09B74.67%
Dec 31, 20222.80B527.74M23.28%
Dec 31, 20212.27B6.63M0.29%
Dec 31, 20202.26B1.46B182.32%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition